EUVIMEDEUVIMED entdecken
Crossref

Mannan-based oral nanovaccine rebalances intestinal immunity against food allergy

Yu Miao, Qiang Zhang, Pengxing Li, Hanlin Zhang, Mengyan Wang, Linfu Chen, Zheyu Kang, Zhuyu Hou, Haibin Zhao, Xinying Lv, Yang Yang, Qian Chen

Science Bulletin · 2026

DOI: 10.1016/j.scib.2026.08.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Bulletin, 2026. Verfasst von Yu Miao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, S…. Hauptthemen laut MEDLINE: Nanovaccines, Mannans, Food Hypersensitivity, Allergens. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Program of Shanghai Academic Research Leader, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Food allergy is an escalating global health challenge. Although oral immunotherapy is clinically promising, its efficacy is limited by gastrointestinal adverse effects, allergen instability, and transient desensitization. We developed mannan-decorated allergen nanoparticles (Mann/Allergen NPs) that protected allergen integrity, prolonged intestinal residence (>8 h), and selectively targeted tolerogenic antigen-presenting cells in the small intestinal lamina propria. Mann/Allergen NPs exhibited uniform size, excellent stability, and enhanced dendritic cell uptake compared with free allergen. In mouse models of food allergy, the nanoparticles induced robust immune reprogramming, including preferential uptake by macrophage-like dendritic cells (DCs), induction of tolerogenic DCs, rebalancing of Th1/Th2 responses, expansion of regulatory T cells (Tregs), and marked suppression of jejunal mast cell infiltration and allergen-specific IgE. In a translational peanut allergy model, a single treatment course conferred durable protection for over four weeks while preserving gut microbial diversity and short-chain fatty acid (SCFA)-producing commensals. These findings establish receptor-targeted nanodelivery as a promising strategy for safe and durable food allergy immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanovaccinesMannansFood HypersensitivityAllergensIntestinesPeanut HypersensitivityAnimalsAdministration, OralMiceDendritic CellsT-Lymphocytes, RegulatoryDesensitization, ImmunologicImmune ToleranceFemaleNanoparticlesHumansImmunoglobulin E

Stichwörter der Autor:innen

Allergen deliveryFood allergyIntestinal immune toleranceOral immunotherapy

Substanzen

NanovaccinesMannansAllergensImmunoglobulin E

Autor:innen und Institutionen

  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou 215123, China; Department of Thoracic Surgery, Shanghai Pulmonar…
  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China; School of Materials Science and Engineering, Tongji University, Shanghai 201804, China.
  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou 215123, China.
  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China; School of Materials Science and Engineering, Tongji University, Shanghai 201804, China. Electro…
  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou 215123, China. Electronic address: chenqian@suda.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Program of Shanghai Academic Research Leader
  • China Postdoctoral Science Foundation

Zitieren

APA

Miao, Y., Zhang, Q., Li, P., Zhang, H., Wang, M., Chen, L., Kang, Z., Hou, Z., Zhao, H., Lv, X., Yang, Y., & Chen, Q. (2026). Mannan-based oral nanovaccine rebalances intestinal immunity against food allergy. Science Bulletin. https://doi.org/10.1016/j.scib.2026.08.014

Vancouver

Miao Y, Zhang Q, Li P, Zhang H, Wang M, Chen L, et al. Mannan-based oral nanovaccine rebalances intestinal immunity against food allergy. Science Bulletin. 2026. doi:10.1016/j.scib.2026.08.014

BibTeX
@article{Miao2026,
  author = {Miao, Yu and Zhang, Qiang and Li, Pengxing and Zhang, Hanlin and Wang, Mengyan and Chen, Linfu and Kang, Zheyu and Hou, Zhuyu and Zhao, Haibin and Lv, Xinying and Yang, Yang and Chen, Qian},
  title = {Mannan-based oral nanovaccine rebalances intestinal immunity against food allergy},
  journal = {Science Bulletin},
  year = {2026},
  doi = {10.1016/j.scib.2026.08.014}
}
Kostenlos starten →